AUTHORIZED DISTRIBUTION • LICENSING PROGRAM

Lepti-P53™ Licensing for Brands

The world’s only patented Leptocarpha rivularis strain—traceable Chilean supply, regulatory-ready documentation, and controlled access through Crown Harvest Distribution.

World’s only patented strain Traceable Chile supply DSHEA-aligned / non-NDI
Apply to License Lepti-P53™
Dossier, COAs, and samples available for qualified partners.
Lepti-P53 botanical source flower
Lepti-P53™ botanical source

Signature Ingredient Program

Lepti-P53™: A controlled, research-forward botanical ingredient system.

Lepti-P53™ is positioned like a premium “hero” ingredient—distributed through a single authorized channel and licensed to qualified B2B partners. Crown Harvest Distribution protects supply integrity, documentation, and brand alignment so your product can stand out with a credible story and consistent inputs.

Authorized channel

Single-distributor access model for consistent sourcing and market control.

Documentation-ready

Partner packets built for B2B evaluation, formulation, and marketing review.

QA + traceability

Origin-to-extract story with defined handling, testing, and manufacturing steps.

Licensing program

Application-based access for brands aligned with long-term positioning.

Origin + Cultivation

Grown in Southern Chile near Patagonia — built on provenance.

Crown Harvest Distribution is built around a single idea: protect what makes Lepti-P53™ special by controlling origin, handling, and downstream access. This is where the story starts—at the farm.

  • Traceable supply: origin-forward ingredient story from cultivation to extraction
  • Controlled access: licensing model designed for select B2B partners
  • Brand-ready narrative: premium positioning similar to top-tier botanical programs

End-to-end

From farm to ingredient — documented and controlled.

B2B Licensing

Apply to license Lepti-P53™ for your brand.

If you want a signature ingredient story with controlled supply, partner documentation, and premium positioning, start here. We review applications and respond with next steps.

Start Licensing Application